Clinical Trials in Georgia

Showing 3101-3120 of 16,324 trials

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

NCT05928936

The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

Chronic Kidney Disease

Emory University156 participantsStarted Nov 2022

Atlanta, Georgia, United States • Decatur, Georgia, United States

COMPLETEDPhase 363 miles

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

NCT06109311

The main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and have inadequate glycemic control with insulin glargine with or without metformin and/or SGLT-2 (sodium-glucose cotransporter-2) inhibitor. The study will last about 46 weeks and may include up to 20 visits.

Type 2 Diabetes

Eli Lilly and Company546 participantsStarted Nov 2023

Chandler, Arizona, United States • Phoenix, Arizona, United States • Bryant, Arkansas, United States +67 more locations

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Find Trials by Condition in Georgia

Mindfulness in Chronic Kidney Disease

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

PMT for MDRO Decolonization

A Study of Sovilnesib in Subjects With Ovarian Cancer

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

PUSH-IT Continuing Enteral Feeds for Tracheostomy

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Staphylococcus Aureus Network Adaptive Platform Trial